|
NYU Grossman School of Medicine: Stephenson Global Scholar Grants Award $6.7 Million to Accelerate Pancreatic Cancer Breakthroughs
The Stephenson Global Pancreatic Cancer Research Institute (SGPCRI) announced the recipients of the 2026 Stephenson Global Scholar Grants. In partnership with City of Hope, one of the largest and most advanced cancer research and treatment organizations in the United States, SGPCRI is awarding $6.7 million to support eight ambitious projects aimed at changing the trajectory of pancreatic cancer.
Shohei Koide, Ph.D., professor of biochemistry and molecular pharmacology and director of Cancer Biologics at NYU Grossman School of Medicine and NYU Perlmutter Cancer Center, is one of the 2026 Stephenson Global Scholar Recipients. His work will advance antibodies targeting the protein LCN2 to help immune cells infiltrate and attack pancreatic tumors. Learn more. |